QNRX Stock Summary and Trading Ideas (Quoin Pharmaceuticals Ltd. - American Depositary Shares | NASDAQ:QNRX)

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Quoin Pharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol QNRX.

As of November 6, 2026, QNRX stock price declined to $3.65 with 23,488 million shares trading.

QNRX has a beta of 1.68, meaning it tends to be more sensitive to market movements. QNRX has a correlation of 0.03 to the broad based SPY ETF.

QNRX has a market cap of $7.33 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, QNRX traded as high as $216.30 and as low as $3.25.

QNRX has underperformed the market in the last year with a price return of -57.4% while the SPY ETF gained +10.8%. QNRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -20.1% and -9.2%, respectively, while the SPY returned -4.1% and -3.2%, respectively.

QNRX support price is $3.59 and resistance is $4.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNRX shares will trade within this expected range on the day.